Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin Academic Article Article uri icon

Overview

MeSH Major

  • Mitral Valve Insufficiency
  • Postoperative Complications
  • Tachycardia, Ventricular

abstract

  • The increased vascularization and mitogenic activity demonstrated by these respective studies suggest that angiogenesis is significantly accelerated by the administration of heparin alone and is accelerated to a greater extent by the administration of aFGF with or without heparin. The aFGF/heparin regimen may represent an optimal means of augmenting collateral vessel growth to relieve ischemia in the clinical setting.

publication date

  • September 9, 1997

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0741-5214(97)70193-9

PubMed ID

  • 9279319

Additional Document Info

start page

  • 302

end page

  • 12

volume

  • 26

number

  • 2